Skip to content

Study for deep brain stimulation in the treatment of Alzheimer disease

Study for deep brain stimulation in the treatment of Alzheimer disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018836
Enrollment
Unknown
Registered
2018-10-12
Start date
2018-10-30
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

Cases:deep brain stimulation

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 65-75 years; 2) Body weight 40-90 kg; 3) Diagnosis of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria; 4) Score between 20 and 26 on the Mini Mental State Examinationsubject have a CDR of 1.0; 5) The memory loss was at least 12 months, with a progressive worsening trend; 6) There were no obvious signs of nervous system examination; 7) If the patient is on AD medication, the regimen must remain stable for the first 3 months of enrollment and for the entire study period; 8) Subjects should have stable and reliable caregivers; 9) The subjects were primary school and above; 10) Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Other causes of dementia; 2. Have suffered from nervous system diseases; 3. psychotic; 4. MRI examination during screening showed significant focal lesions; 5. Cannot tolerate MRI or has MRI contraindications; 6. Abnormal laboratory indicators; 7. Uncontrolled high blood pressure; 8. Have unstable or serious heart, lung, liver, kidney, hematopoietic system diseases; 9. Alcohol or drug abuse; 10. Other clinical trials were conducted within 30 days before the screening visit; 11. The researchers considered it impossible for the subject to complete the study; 12. Surgical contraindications.

Design outcomes

Primary

MeasureTime frame
Cognitive function;

Countries

China

Contacts

Public ContactDou wanchen

Peking Union Medical College Hospital

douwanchen@126.com+86 13391976196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026